Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma

被引:223
作者
Engelen, MJA
Kos, HE
Willemse, PHB
Aalders, JG
de Vries, EGE
Schaapveld, M
Otter, R
van der Zee, AGJ
机构
[1] Univ Groningen, Med Ctr, Dept Obstet & Gynecol, CMC 5,Div Gynecol Oncol, NL-9700 RB Groningen, Netherlands
[2] Comprehens Canc Ctr N Netherlands, Dept Epidemiol & Stat, Groningen, Netherlands
[3] Univ Groningen, Med Ctr, Div Med Oncol, Dept Internal Med, NL-9700 RB Groningen, Netherlands
关键词
general gynecologist; gynecologic oncologist; gynecologic carcinoma; medical oncologist; patterns of care; primary surgery;
D O I
10.1002/cncr.21616
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Consultant gynecologic oncologists from the regional Comprehensive Cancer Center assisted community gynecologists in the surgical treatment of patients with ovarian carcinoma when they were invited. For this report, the authors evaluated the effects of primary surgery by a gynecologic oncologist on treatment outcome. METHODS. The hospital files from 680 patients with epithelial ovarian carcinoma who were diagnosed between 1994 and 1997 in the northern part of the Netherlands were abstracted. Treatment results were analyzed according to the operating physician's education by using survival curves and univariate and multivariate Cox regression analyses. RESULTS. Primary surgery was performed on 184 patients by gynecologic oncologists, and on 328 patients by general gynecologists. Gynecologic oncologists followed surgical guidelines more strictly compared with general gynecologists (patients with International Federation of Gynecology and Obstetrics [FIGO] Stage I-II disease, 55% vs. 33% [P = 0.01]; patients with FIGO Stage III disease,60% vs. 40% [P = 0.003]) and more often removed all macroscopic tumor in patients with FIGO Stage III disease (24% vs. 12%; P = 0.02). When patients were stratified according to FIGO stage, the 5-year overall Survival rate was 86% versus 70% (P = 0.03) for patients with Stage I-II disease and 21% versus 13% (P = 0.02) for patients with Stage III-IV disease who underwent surgery by gynecologic oncologists and general gynecologists, respectively. The hazards ratio for patients who underwent surgery by gynecologic oncologists was 0.79 (95% confidence interval [95% CI], 0.61-1.03; adjusted for patient age, disease stage, type of hospital, and chemotherapy); when patients age 75 years and older were excluded, the hazards ratio fell to 0.71 (95% CI, 0.54-0.94) in multivariate analysis. CONCLUSIONS. The surgical treatment of patients with ovarian carcinoma by gynecologic oncologists occurred more often according to surgical guidelines, tumor removal more often was complete, and survival was improved.
引用
收藏
页码:589 / 598
页数:10
相关论文
共 33 条
[1]  
[Anonymous], 1986, GYNECOL ONCOL
[2]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[3]   Cancer of the ovary [J].
Cannistra, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2519-2529
[4]   A population-based study of patterns of care for ovarian cancer: Who is seen by a gynecologic oncologist and who is not? [J].
Carney, ME ;
Lancaster, JM ;
Ford, C ;
Tsodikov, A ;
Wiggins, CL .
GYNECOLOGIC ONCOLOGY, 2002, 84 (01) :36-42
[5]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]   THE IMPACT OF SUBSPECIALTY TRAINING ON THE MANAGEMENT OF ADVANCED OVARIAN-CANCER [J].
EISENKOP, SM ;
SPIRTOS, NM ;
MONTAG, TW ;
NALICK, RH ;
WANG, HJ .
GYNECOLOGIC ONCOLOGY, 1992, 47 (02) :203-209
[7]   What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? [J].
Eisenkop, SM ;
Spirtos, NM .
GYNECOLOGIC ONCOLOGY, 2001, 82 (03) :489-497
[8]  
Griffiths C T, 1975, Natl Cancer Inst Monogr, V42, P101
[9]  
GRIFFITHS CT, 1979, CANCER TREAT REP, V63, P235
[10]   Hospital and physician volume or specialization and outcomes in cancer treatment: Importance in quality of cancer care [J].
Hillner, BE ;
Smith, TJ ;
Desch, CE .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) :2327-2340